Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06517914 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06517914 · ClinicalTrials.gov record · last posted 2026-07-28

A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants

Name: A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants — clinical trial record (NCT06517914)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 1

SponsorYuhan Corporation

Started2024-07-29

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This is a randomized, double-blind, first-in-human study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of YH35995

Protocol amendment history 3 changes detected by DataLookout

2026-07-29

Enrollment closed, study ongoing

2026-07-29

Primary completion moved earlier: 2027-06 → 2027-03

2026-07-29

Completion moved earlier: 2027-06 → 2027-03

Trial Details

NCT Number	NCT06517914
Lead Sponsor	Yuhan Corporation
Conditions	Healthy Participants
Enrollment	94 participants
Start Date	2024-07-29
Primary Completion	2027-03 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-07-28